The progress of early cancer diagnoses in clinical laboratories

12월 26, 2024 Bullet 기사

Early diagnosis of cancer is critically important for the ideal prognosis of cancer patients. cfDNA-based new technologies have the potential to be the methodology for liquid biopsy of early cancer patients. Dr Xu Songxiao of Zhejiang Cancer Hospital discusses the progress of cfDNA methylation, fragmentome and microbiome studies, as well as the combined application of current biomarkers in this talk at RED 2024.

 

동일한 주제에 대한 추가 정보

Select a related post from the options below.

권장 주제

염기서열 분석레드 2020희귀 질환
다음 읽기
Scroll to Top